Asia-Pacific Digital Pathology Market to Reach $2,736.9 Million by 2035, Driven by AI Integration

Asia-Pacific digital pathology market was valued at $328.1 million in 2025 and is projected to reach $2,736.9 million by 2035, growing at a CAGR of 23.7% during the forecast period (2026–2035). The integration of AI-driven technologies into digital pathology is transforming the landscape of diagnostic practices in the Asia-Pacific region. AI algorithms are being utilized to assist pathologists in analyzing complex pathology images, improving diagnostic accuracy and reducing human error. These technologies enable automated detection of patterns, quantification of tissue characteristics, and identification of potential biomarkers, significantly enhancing the efficiency of diagnosis. AI-driven digital pathology also supports faster processing and higher throughput, enabling laboratories to handle larger case volumes. As a result, healthcare providers in the region are increasingly adopting AI solutions to support personalized medicine, improve patient outcomes, and optimize clinical workflows. This trend is expected to accelerate as AI technology continues to evolve and prove its reliability in clinical settings.

Browse the full report description of “Asia-Pacific Digital Pathology Market Size, Share & Trends Analysis Report by Product (Scanner Device, Software, and Storage System), by Application (Teleconsultation, Disease Diagnosis, Drug Discovery, and Other), and by End-User (Biotechnology & Pharmaceutical Companies, Hospitals, and Others), Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/asia-pacific-digital-pathology-market

The adoption of AI-driven digital pathology systems is gaining momentum across the Asia-Pacific region in nations such as China, India and Japan, with several healthcare institutions embracing these technologies to enhance diagnostic precision and streamline workflows. For instance, in January 2026, Kameda Medical Center implemented an AI-driven digital pathology system as part of its transition to a new enterprise pathology platform. The system, supplied by Swedish medical technology company Sectra, enables digitisation of pathology workflows, remote case review, and collaboration through digital tissue images. The rollout follows a contract signed last year and builds on the hospital’s nearly decade-long experience in digital pathology.

Market Players Outlook

The major companies operating in the Asia-Pacific digital pathology market include Indica Labs LLC., Inc., F. Hoffmann-La Roche Ltd. (Ventana), Leica Biosystems Nussloch GmbH, Koninklijke Philips N.V., and Hamamatsu Photonics K.K., among others.

• Lunit announced a strategic partnership with CellCarta to integrate its AI-powered pathology solutions into global clinical trial workflows. This collaboration aims to enhance clinical trials by offering faster, scalable insights into tumor biology and advancing precision oncology. CellCarta, with its global network of CAP-accredited/CLIA-certified labs, has supported over 1,000 clinical studies, including 75 Phase III PMA trials.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product
  • By Application
  • By End-User
• Competitive Landscape - Indica Labs LLC., Inc., F. Hoffmann-La Roche Ltd. (Ventana), Leica Biosystems Nussloch GmbH, Koninklijke Philips N.V., and Hamamatsu Photonics K.K., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Digital Pathology Market Report Segment

By Product Type

• Scanner Device
• Software
• Storage System

By Application

• Teleconsultation
• Disease Diagnosis
• Drug Discovery
• Other

By End-User

• Biotechnology & Pharmaceutical Companies
• Hospitals
• Others

Asia-Pacific Digital Pathology Market Report Segment by Region

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
• Rest of Asia-Pacific

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-digital-pathology-market